Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
32
Number of overlapping holdings
25.2%
% of BMED's 140 holdings also in FMED
55.2%
% of FMED's 65 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
BOSTON SCIENTIFIC CORP | 3.7% | 5.6% | 3.7% |
|
INTUITIVE SURGICAL INC | 2.8% | 3.8% | 2.8% |
|
ALNYLAM PHARMACEUTICALS INC | 2.6% | 4.4% | 2.6% |
 |
ARGENX SE ADR | 2.4% | 2.9% | 2.4% |
|
DANAHER CORP | 2.0% | 3.9% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to FMED
|
AMERISOURCEBERGEN CORP | 3.4% |
|
AMGEN INC | 2.5% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.4% |
|
BIOMARIN PHARMACEUTICAL INC | 1.9% |
|
QIAGEN NV | 1.8% |
|
MCKESSON CORP | 1.7% |
|
WATERS CORP | 1.6% |
|
WEST PHARMACEUTICAL SERVICES | 1.4% |
 |
GERRESHEIMER AG | 1.4% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.4% |
BMED Underweight Relative to FMED
|
REGENERON PHARMACEUTICALS | -3.8% |
|
INSULET CORP | -3.4% |
|
UNITEDHEALTH GROUP INC | -3.0% |
|
UCB SA | -2.3% |
|
ELI LILLY & CO | -2.3% |
|
EXACT SCIENCES CORP | -2.3% |
|
ROYALTY PHARMA PLC CLASS A | -2.1% |
|
LIFESTANCE HEALTH GROUP, INC. | -2.0% |
|
VEEVA SYSTEMS INC-CLASS A | -1.9% |
|
DANAHER CORP | -1.9% |